Unidad de Regeneración y Trasplante cardíaco, Instituto de Investigación Sanitaria La Fe, Valencia, España, Spain.
Unidad de Genética, Hospital Universitario La Fe, Valencia, España, Spain.
Clin Genet. 2021 Feb;99(2):269-280. doi: 10.1111/cge.13879. Epub 2020 Nov 23.
Marfan syndrome (MFS) is a systemic connective tissue disorder caused by mutations in the fibrillin-1 (FBN1) gene, and cardiovascular involvement is the leading cause of mortality. We sought to examine the genotype/phenotype realtionship in 61 consecutive patients with a phenotype and genotype compatible with MFS. The FBN1 gene was analyzed by massive sequencing using a hybridization capture-based target enrichment custom panel. Forty-three different variants of FBN1 were identified, of which 17 have not been previously reported. The causal variants of MFS were grouped into mutations resulting in haploinsufficiency (HI group; 23 patients) and mutations producing a dominant-negative effect (DN group; 38 patients). Patient information was collected from electronic medical records and clinical evaluation. While no significant differences were found between the two groups, the HI group included more cases with aortic dissection and occurring at a younger age that the DN group (34.7% vs. 15.8%; p = 0.160). Irrespective of the mutation group, males presented with a higher probability of aortic involvement (4-fold higher risk than females) and aortic dissections events occurred at younger ages. Patients with DN variants carrying a cysteine substitution had a higher incidence of ectopia lentis.
马凡综合征(MFS)是一种由原纤维蛋白 1(FBN1)基因突变引起的系统性结缔组织疾病,心血管受累是导致死亡的主要原因。我们旨在研究 61 例与 MFS 表型和基因型相匹配的连续患者的基因型/表型关系。使用基于杂交捕获的靶向富集定制面板进行大规模测序分析 FBN1 基因。共发现 43 种不同的 FBN1 变体,其中 17 种以前未报道过。MFS 的致病变体分为导致单倍不足的突变(HI 组,23 例)和产生显性负效应的突变(DN 组,38 例)。从电子病历和临床评估中收集患者信息。虽然两组之间没有发现显著差异,但 HI 组包括更多的主动脉夹层和更年轻的发病年龄的病例,而 DN 组则没有(34.7% vs. 15.8%;p = 0.160)。无论突变组如何,男性主动脉受累的可能性更高(比女性高 4 倍),且主动脉夹层发生的年龄更小。携带半胱氨酸取代的 DN 变体的患者患有晶状体异位的发生率更高。